IXJ beats BBH on yield, volatility, and long-term returns
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
The article compares iShares Global Healthcare ETF (IXJ) and VanEck Biotech ETF (BBH) for 2026 healthcare investing. BBH offers higher short-term returns with a concentrated biotech focus. IXJ provides broader global diversification, lower volatility, better long-term performance, and a higher dividend yield. Cost, performance, risk, and portfolio contents are analyzed. IXJ is recommended over BBH.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.